Achieving an optimal therapeutic level is crucial in effectively eradicating cancer cells during
treatment. However, conventional chemotherapy-associated systemic administration of …

The functionalization of liposomes with monoclonal antibodies is a potential strategy to
increase the specificity of liposomes and reduce the side-effects associated with …

Site-specific delivery of chemotherapeutics using actively targeted-stimuli-responsive
liposomes is a promising approach to enhance the therapeutic efficiency of anti-cancer …

Cancer is one of the deadliest diseases in this era. Since conventional treatment has many
side effects, its use is limited, which augments the need for new smart drug delivery systems …

Targeted liposomes are designed to target specific receptors overexpressed on the surfaces
of cancer cells. This technique ensures site-specific drug delivery to reduce undesirable side …

The successful targeting of tumors can be achieved by conjugating targeting moieties to
nanoparticles. These modifications allow nannocarriers to achieve greater targeting …

The use of targeted liposomes encapsulating chemotherapy drugs enhances the specific
targeting of cancer cells, thus reducing the side effects of these drugs and providing patient …

Targeted liposomes have high potentials in the specific and effective delivery of their loaded
therapeutic agents to the tumour site. Once at the tumour site, it is important that these …

Numerous nanocarriers are currently being investigated as drug delivery vehicles for
transporting chemotherapeutics to cancer cells. Our research group has recently …

Liposomes are the most successful nanoparticles used to date to load and deliver
chemotherapeutic agents to cancer cells. They are nano-sized vesicles made up of …